(Q51785972)

English

A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells.

scientific article published in November 2008

Statements

A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit